CorVel Corporation Reports Strong Growth in 2026 Annual Results
CorVel Corporation, a prominent nationwide provider of medical cost containment and managed care services, has released its annual report for the fiscal year 2026, showcasing impressive growth across key financial metrics. The company's focus on enhancing network solutions and patient management services has positioned it well within the competitive landscape of healthcare management.
1. Overview of Financial Performance
In fiscal year 2026, CorVel reported total revenues of $959 million, marking a significant 7% increase from the $896 million reported in 2025. This growth can be primarily attributed to heightened activity in network solutions with existing customers. The company's gross profit also saw a notable rise, reaching $233 million, up from $210 million in the previous year, which translates to an 11% increase.
Revenue Breakdown
CorVel's revenue generation is anchored in two primary segments:
- Network Solutions Services: Revenue surged to $362 million in 2026, up from $314 million in 2025, reflecting a robust 15% growth. This increase is largely driven by enhanced bill review programs and the expansion of its CareIQ network.
- Patient Management Services: This segment also contributed positively, with revenues growing to $596 million from $581 million, representing a 3% increase.
Income Statement Highlights
The following financial highlights from the income statement reflect CorVel's strong performance in fiscal year 2026:
- Net Income: Increased by 16% to $110.3 million from $95.2 million in fiscal 2025.
- Diluted Earnings Per Share: Rose from $1.83 to $2.14, a 17% increase attributed to higher net income.
- Operating Expenses: General and administrative expenses increased slightly to $89.7 million from $88.9 million.
| May 2025 | May 2026 | |
|---|---|---|
Net Income | 95.16M | 110.3M |
Profit | 95.16M | 110.3M |
Net Income Continuing | 95.16M | 110.3M |
Income Tax Expense | 25.65M | 32.78M |
Pretax Income | 120.8M | 143.1M |
Operating Income | 120.8M | 143.1M |
Revenue | 895.5M | 958.5M |
Costs and Expenses | 774.7M | 815.3M |
Cost of Revenue | 685.8M | 725.6M |
Operating Expenses | 88.90M | 89.73M |
Selling, General & Administrative | 88.90M | 89.73M |
2. Balance Sheet Analysis
CorVel's balance sheet remains robust, reflecting a solid financial position as of March 31, 2026. Total assets increased to $642.9 million from $545.9 million in 2025. Notably:
- Current Assets: Grew to $462.2 million, with cash and cash equivalents rising to $233 million, a strategic position for liquidity management.
- Total Equity: Increased to $394.2 million, underlining the company's strong capital base.
| May 2025 | May 2026 | |
|---|---|---|
Total Assets | 545.9M | 642.9M |
Total Current Assets | 386.6M | 462.2M |
Cash and Equivalents | 170.5M | 233.0M |
Accounts Receivable | 104.1M | 101.3M |
Prepaid Expenses | 10.50M | 12.20M |
Other Current Assets | 101.4M | 115.7M |
Total Non-current Assets | 159.2M | 180.6M |
Intangible Assets | 37.25M | 37.07M |
Non-current Deferred Tax Assets | 8.70M | 3.92M |
Net PP&E | 92.05M | 117.9M |
Lease Assets | 20.82M | 21.16M |
Other Non-current Assets | 454K | 618K |
Total Liabilities and Equity | 545.9M | 642.9M |
Total Liabilities | 223.9M | 248.7M |
Total Current Liabilities | 204.0M | 228.0M |
Accounts Payable and Accrued Liabilities | 187.2M | 203.5M |
Other Current Liabilities | 16.79M | 24.55M |
Total Non-current Liabilities | 19.95M | 20.68M |
Other Non-current Liabilities | 19.95M | 20.68M |
Total Equity and Non-controlling Interests | 321.9M | 394.2M |
Total Equity | 321.9M | 394.2M |
3. Cash Flow Dynamics
Examining the cash flow statement, CorVel demonstrated effective cash management strategies:
- Net Cash Provided by Operating Activities: Increased significantly to $155.6 million from $127.3 million, driven by improved net income and accounts receivable management.
- Investing Activities: Cash used rose to $45.4 million, primarily due to investments in software development.
- Financing Activities: Increased outflows to $47.8 million reflected substantial share repurchases, with 782,744 shares repurchased at an average price of $71.81.
| May 2025 | May 2026 | |
|---|---|---|
Net Change in Cash | 65.02M | 62.48M |
Net Cash from Operating Activities | 127.3M | 155.6M |
Operating Profit | 95.16M | 110.3M |
Adjustment to Operating Profit | 32.15M | 45.29M |
Net Cash from Investing Activities | -35.75M | -45.35M |
Productive Assets | 35.75M | 53.84M |
Other Investing Activities | 0 | 8.48M |
Net Cash from Financing Activities | -26.53M | -47.79M |
Equity Issuance/Repurchase | -26.53M | -43.51M |
Other Financing Activities | 0 | -4.28M |
4. Outlook and Challenges
Despite the positive growth trajectory, CorVel faces challenges such as inflationary pressures and competitive pricing. The company has acknowledged these factors but remains optimistic, emphasizing that the impacts on revenues and net income were not deemed material for fiscal 2026. CorVel continues to focus on operational efficiency and strategic investment in technology to sustain its competitive edge.
5. Conclusion
CorVel Corporation's fiscal year 2026 results underscore its successful execution of its business strategy, driven by increased utilization of network solutions services. As the company navigates the complexities of the healthcare landscape, its commitment to cost containment and quality care positions it for continued success. With a solid financial foundation and a strategic focus on innovation, CorVel is well-prepared to tackle future challenges while delivering value to its shareholders and clients alike.
